Xolair 150 mg

XOLAIR 150 MG is a subcutaneous solution containing omalizumab, used for managing allergic conditions. This medication is designed to help control symptoms in patients with specific allergies.

XOLAIR 150 MG is primarily used for the treatment of moderate to severe allergic asthma in adults and adolescents. It is also indicated for chronic idiopathic urticaria in adults and children. This medication works by targeting immune system responses to allergens, helping to reduce symptoms such as difficulty breathing and persistent skin reactions.

Common effects of XOLAIR 150 MG may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience headaches, nausea, or fatigue. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

XOLAIR 150 MG should be administered under medical supervision. Patients with a history of severe allergic reactions should inform their healthcare provider before use. The solution should be stored properly and used as directed to minimize the risk of adverse effects.

XOLAIR 150 MG may interact with other medications, particularly those that affect the immune system. It is important to disclose all current medications to a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this medication.